The CEO of \u201cAnaliza\u201d, Nuria Mart\u00edn Gil, talks on \u201cLa Sexta\u201d about the technological developments of clinical analyses and the importance of the diagnostic procedures until a result is reached. Not merely providing a result, but rather taking into consideration the particulars of the patient in order to adapt the prescription and interpretation of the results.<\/p>\n
<\/p>\n
\u201cWe actively promote precision medicine so as to adapt the treatments to the individual characteristics of the patient\u201d<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
The diagnostic tools include a wide range of tests that help to establish a diagnosis, identify illnesses, implement a treatment or prevent the development of illnesses.<\/p>\n
<\/p>\n
\u201cDiagnostic tests constitute a fundamental tool in medicine, thanks to diagnostic testing in 80% of cases, a correct and accurate diagnosis is obtained for a pathology.\u201d<\/p>\n
Link video:<\/p>\n
<\/p>","protected":false},"excerpt":{"rendered":"
The CEO of \u201cAnaliza\u201d, Nuria Mart\u00edn Gil, talks on \u201cLa Sexta\u201d about the technological developments of clinical analyses and the importance of the diagnostic procedures until a result is reached. Not merely providing a result, but rather taking into consideration the particulars of the patient in order to adapt the prescription and interpretation of the… <\/p>\n